This article provides a practical explanation of MACRA and the Quality Payment Program and what they mean for practicing urologists.
Two topics of particular relevance at the 2017 Joint Advocacy Conference were IPAB repeal and medical liability reform, both of which have legislative initiatives currently gaining momentum in Congress.
The era of value-based health care has arrived. And while the idea of basing reimbursement on quality and efficiency rather than volume of care is good in theory, the majority of urologists say it will be difficult to carry out, according to Urology Times' 2016 State of the Specialty survey.
In this exclusive interview, Andy Slavitt, acting administrator for the Centers for Medicare & Medicaid Services, discusses alternative payment models, outlines what resources are available for practices, and provides an overview of the three options practices have for participation in the Quality Payment Program.
Urologists and other physicians who serve Medicare patients face some new decisions now that the Centers for Medicare & Medicaid Services has proposed new regulations implementing last year’s fee schedule reform law, while also replacing the existing meaningful use program with a more flexible approach to technology and electronic health records.
In a series of articles this year, Robert A. Dowling, MD, will examine what you need to know about the law, what the CMS proposed rule for implementation implies for the near and long-term future, and—when it is issued later this year—what the final rule means to your urology practice.